Cargando…
EGCG Alleviates Obesity-Induced Myocardial Fibrosis in Rats by Enhancing Expression of SCN5A
OBJECT: Obesity is an increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. Obesity could increase the risk of myocardial fibrosis. (-)-Epigallocatechin-3-gallate (EGCG) is the most abundant substance in gre...
Autores principales: | Yi, Haoan, Liu, Cong, Shi, Jing, Wang, Shuo, Zhang, Haoxin, He, Yongshu, Tao, Jianping, Li, Shude, Zhang, Renfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098820/ https://www.ncbi.nlm.nih.gov/pubmed/35571212 http://dx.doi.org/10.3389/fcvm.2022.869279 |
Ejemplares similares
-
Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
por: Liu, Mao, et al.
Publicado: (2021) -
Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation
por: Chen, Zhi-Teng, et al.
Publicado: (2021) -
Suppression of SMOC2 alleviates myocardial fibrosis via the ILK/p38 pathway
por: Rui, Huang, et al.
Publicado: (2023) -
Uncovering Potential lncRNAs and mRNAs in the Progression From Acute Myocardial Infarction to Myocardial Fibrosis to Heart Failure
por: Wang, Shuo, et al.
Publicado: (2021) -
Disease Modifiers of Inherited SCN5A Channelopathy
por: Verkerk, Arie O., et al.
Publicado: (2018)